1. Home
  2. VATE vs ONCY Comparison

VATE vs ONCY Comparison

Compare VATE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • ONCY
  • Stock Information
  • Founded
  • VATE 1994
  • ONCY 1998
  • Country
  • VATE United States
  • ONCY Canada
  • Employees
  • VATE 4024
  • ONCY N/A
  • Industry
  • VATE Metal Fabrications
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • VATE Industrials
  • ONCY Health Care
  • Exchange
  • VATE Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • VATE 82.6M
  • ONCY 103.8M
  • IPO Year
  • VATE 1996
  • ONCY 1999
  • Fundamental
  • Price
  • VATE $6.10
  • ONCY $1.19
  • Analyst Decision
  • VATE
  • ONCY Strong Buy
  • Analyst Count
  • VATE 0
  • ONCY 2
  • Target Price
  • VATE N/A
  • ONCY $4.00
  • AVG Volume (30 Days)
  • VATE 50.3K
  • ONCY 903.7K
  • Earning Date
  • VATE 11-06-2024
  • ONCY 11-05-2024
  • Dividend Yield
  • VATE N/A
  • ONCY N/A
  • EPS Growth
  • VATE N/A
  • ONCY N/A
  • EPS
  • VATE N/A
  • ONCY N/A
  • Revenue
  • VATE $1,364,600,000.00
  • ONCY N/A
  • Revenue This Year
  • VATE N/A
  • ONCY N/A
  • Revenue Next Year
  • VATE N/A
  • ONCY N/A
  • P/E Ratio
  • VATE N/A
  • ONCY N/A
  • Revenue Growth
  • VATE N/A
  • ONCY N/A
  • 52 Week Low
  • VATE $3.25
  • ONCY $0.84
  • 52 Week High
  • VATE $14.60
  • ONCY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • VATE 71.67
  • ONCY 52.51
  • Support Level
  • VATE $6.18
  • ONCY $1.17
  • Resistance Level
  • VATE $6.49
  • ONCY $1.28
  • Average True Range (ATR)
  • VATE 0.43
  • ONCY 0.09
  • MACD
  • VATE 0.05
  • ONCY -0.01
  • Stochastic Oscillator
  • VATE 86.72
  • ONCY 28.00

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: